(Q43255562)

17 November 2017

title

Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells (English)

1 reference

anaplastic thyroid carcinoma

17 November 2017

0 references

angiogenesis inhibitor

1 reference

1 reference

1 reference

Wenbo Zhu

1

1 reference

17 November 2017

Songmin He

2

1 reference

17 November 2017

Yan Li

3

1 reference

17 November 2017

Pengxin Qiu

4

1 reference

17 November 2017

Minfeng Shu

5

1 reference

17 November 2017

Yanqiu Ou

6

1 reference

17 November 2017

Yuehan Zhou

7

1 reference

17 November 2017

Tiandong Leng

8

1 reference

17 November 2017

Jun Xie

9

1 reference

17 November 2017

Xiaoke Zheng

10

1 reference

17 November 2017

Dong Xu

11

1 reference

17 November 2017

Xingwen Su

12

1 reference

17 November 2017

Guangmei Yan

13

1 reference

17 November 2017

publication date

23 October 2009

1 reference

17 November 2017

published in

Vascular Pharmacology

1 reference

17 November 2017

volume

52

1 reference

17 November 2017

issue

1-2

1 reference

17 November 2017

page(s)

46-54

1 reference

Nuclear factor-kappaB: the enemy within

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Angiogenesis in cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Endothelial cells and VEGF in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Endostatin induces endothelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Angiogenesis as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Cancer: looking outside the genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: Triptolide and tripdiolide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Triptolide functions as a potent angiogenesis inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Angiogenesis in thyroid cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Angiogenesis in benign and malignant thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Anaplastic thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

The involvement of endothelial progenitor cells in tumor angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.006

10.1016/J.VPH.2009.10.006

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference